<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=2653956&amp;fmt=gif">
Image Overlay - NYU Langone Seeking 1,000 Clinical Trial Participants for COVID-19 Clinical Trial
Image Overlay - NYU Langone Seeking 1,000 Clinical Trial Participants for COVID-19 Clinical Trial

NYU Langone Seeking 1,000 Clinical Trial Participants for COVID-19 Clinical Trial

NYU Langone Seeking 1,000 Clinical Trial Participants for COVID-19 Clinical Trial

AstraZeneca’s COVID-19 vaccine will be tested at an NYU Langone trial site in Long Island, in addition to four other sites in New York City. The NYU Langone’s Vaccine Center is seeking to enroll 1,000 participants aged 18 to 85 to enroll in the phase III large-scale clinical trial, which is sponsored by the National Institutes of Health. This trial is part of the ongoing 30,000-person trial of the vaccine being tested globally. With our headquarters in Allentown, Pennsylvania and 21 strategically located depots around the world, Yourway is well-positioned to distribute clinical trial supplies for even the most critical and extensive trials.

Back to Index
Stay Connected

Want to stay informed about the latest news, updates, and opportunities at Yourway?

Join our newsletter mailing list to never miss an update!

Media

Upcoming Events

Longwood Healthcare Leaders

October 27-28, 2025
Mandarin Oriental Hotel, Boston

Precision in Pharma Supply Chain & Logistics Summit

November 17-18, 2025
Revere Hotel Boston Common

Media

Articles

Mitigating Risk in Drug Development: The Strategic Role of Phase I Research Units

Open chat
Come chat with us!
Hello! How can I help you?